An Extended Access Program (EAP) for Participants Who Have Completed Rufinamide Study E2080-G000-303
Condition: Lennox Gastaut Syndrome Intervention: Drug: Rufinamide Sponsor: Eisai Inc. Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2018 Category: Research Source Type: clinical trials
